Header cover image

Hong Kong Pharmaceuticals & Biotech High And Sustainable

Results

2

1 new

Companies in a sound financial shape with a dividend yield of more than 5%.

2 companies

JBM (Healthcare)

Market Cap: HK$2.3b

An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.

New

2161

HK$2.81

7D

-6.3%

1Y

52.7%

Jacobson Pharma

Market Cap: HK$2.5b

Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.

2633

HK$1.26

7D

-6.7%

1Y

57.5%